Hello, everyone, and how are you today? We are doing just swell, thank you, courtesy of a delightfully shiny sun and cool spring breeze wafting about the Pharmalot campus. Moreover, our short people have departed successfully for their respective destinations, which means we can more easily focus on the matters at hand. And there are several of them. So time to get cracking. Here are a few items of interest, meanwhile, to help you get moving yourselves. As always, we hope you have a productive day and conquer the world. And please do keep in touch. …

Bernadette Pajer doesn’t trust the pharmaceutical industry and she doesn’t trust vaccines, USA Today explains. The founder of a Washington state advocacy group says her dual distrust shouldn’t come as any surprise. She notes drug makers have a “pretty poor record over all” on safety and transparency. Not to mention the opioid crisis, though Pajer often does. Pajer is not alone. As distrust of the pharmaceutical industry grows, so too has the anti-vaccination movement. And that is a critical issue as the number of measles cases in the U.S. surges toward a record.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy